Transient increase in CSF GAP-43 concentration after ischemic stroke.
Åsa SandeliusNicholas C CullenÅsa KällénLars RosengrenCrister JensenVesna KostanjeveckiManu VandijckHenrik ZetterbergKaj BlennowPublished in: BMC neurology (2018)
The transient increase of CSF GAP-43 is important to take into account when used as a biomarker for other neurodegenerative diseases such as Alzheimer's disease. Furthermore, GAP-43 may be a marker of neuronal responses after stroke and additional studies confirming the potential of CSF GAP-43 to reflect severity and outcome of stroke in larger cohorts are warranted.